These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 1418927)

  • 1. Transgenic animals in lipoprotein research.
    Aalto-Setälä K
    Ann Med; 1992 Oct; 24(5):405-9. PubMed ID: 1418927
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease.
    Marais AD
    Pathology; 2019 Feb; 51(2):165-176. PubMed ID: 30598326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.
    Jong MC; Dahlmans VE; van Gorp PJ; van Dijk KW; Breuer ML; Hofker MH; Havekes LM
    J Clin Invest; 1996 Nov; 98(10):2259-67. PubMed ID: 8941642
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased sphingomyelin content of plasma lipoproteins in apolipoprotein E knockout mice reflects combined production and catabolic defects and enhances reactivity with mammalian sphingomyelinase.
    Jeong Ts; Schissel SL; Tabas I; Pownall HJ; Tall AR; Jiang X
    J Clin Invest; 1998 Feb; 101(4):905-12. PubMed ID: 9466986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Apolipoprotein A-I, E, C-III and LDL-receptor mRNA expression in liver diseases].
    Fukushima N; Yamamoto K; Ozaki I; Sakai T
    Nihon Rinsho; 1993 Feb; 51(2):407-13. PubMed ID: 8464155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of hyperlipidaemia in apolipoprotein C1 transgenic mice by adenovirus-mediated gene delivery of the low-density-lipoprotein receptor, but not by the very-low-density-lipoprotein receptor.
    Jong MC; van Dijk KW; Dahlmans VE; Van der Boom H; Kobayashi K; Oka K; Siest G; Chan L; Hofker MH; Havekes LM
    Biochem J; 1999 Mar; 338 ( Pt 2)(Pt 2):281-7. PubMed ID: 10024503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatic apo E expression is required for remnant lipoprotein clearance in the absence of the low density lipoprotein receptor.
    Linton MF; Hasty AH; Babaev VR; Fazio S
    J Clin Invest; 1998 Apr; 101(8):1726-36. PubMed ID: 9541504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein CI causes hypertriglyceridemia independent of the very-low-density lipoprotein receptor and apolipoprotein CIII in mice.
    van der Hoogt CC; Berbée JF; Espirito Santo SM; Gerritsen G; Krom YD; van der Zee A; Havekes LM; van Dijk KW; Rensen PC
    Biochim Biophys Acta; 2006 Feb; 1761(2):213-20. PubMed ID: 16478678
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into apolipoprotein C metabolism from transgenic and gene-targeted mice.
    Jong MC; Havekes LM
    Int J Tissue React; 2000; 22(2-3):59-66. PubMed ID: 10937355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of transgenic mice in lipoprotein metabolism and atherosclerosis research.
    Havekes LM; van Vlijmen BJ; Jong MC; van Dijk KW; Hofker MH
    Prostaglandins Leukot Essent Fatty Acids; 1997 Oct; 57(4-5):463-6. PubMed ID: 9430397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Interaction between genes and diet as a determinant of the plasma levels of cholesterol].
    López Miranda J; Ordovás JM; Pérez Jiménez F
    Med Clin (Barc); 1998 Oct; 111(14):546-51. PubMed ID: 9859082
    [No Abstract]   [Full Text] [Related]  

  • 12. Increased prebeta-high density lipoprotein, apolipoprotein AI, and phospholipid in mice expressing the human phospholipid transfer protein and human apolipoprotein AI transgenes.
    Jiang X; Francone OL; Bruce C; Milne R; Mar J; Walsh A; Breslow JL; Tall AR
    J Clin Invest; 1996 Nov; 98(10):2373-80. PubMed ID: 8941656
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lipoprotein and receptor interactions in vivo.
    Herz J; Willnow TE
    Curr Opin Lipidol; 1995 Apr; 6(2):97-103. PubMed ID: 7773575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transgenic mouse models of lipoprotein metabolism and atherosclerosis.
    Breslow JL
    Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8314-8. PubMed ID: 8378301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of apoproteins in disorders of lipoprotein metabolism.
    Frohlich JJ; Seccombe DW; Pritchard PH
    Clin Biochem; 1989 Feb; 22(1):51-6. PubMed ID: 2650923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent advances in lipoprotein metabolism].
    Miyazaki A; Horiuchi S
    Nihon Rinsho; 1993 Aug; 51(8):1954-60. PubMed ID: 8411656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3.
    Jong MC; Hofker MH; Havekes LM
    Arterioscler Thromb Vasc Biol; 1999 Mar; 19(3):472-84. PubMed ID: 10073946
    [No Abstract]   [Full Text] [Related]  

  • 18. [Disorders of apolipoproteins and lipoprotein receptors].
    Itakura H; Matsumoto A
    Nihon Rinsho; 1990 Nov; 48(11):2666-74. PubMed ID: 2125327
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the role of lipoprotein metabolism genes in systemic cationic liposome-mediated gene transfer in vivo.
    Mounkes LC; Zhong W; de Silva HV; Handumrongkul C; Desai B; Tse E; Taylor JM; Debs RJ
    Hum Gene Ther; 2001 Nov; 12(16):1939-54. PubMed ID: 11686936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polymorphisms of the genes encoding apoproteins A-I, B, C-III, and E and LDL receptor, and cholesterol and LDL metabolism during increased cholesterol intake. Common alleles of the apoprotein E gene show the greatest regulatory impact.
    Gylling H; Kontula K; Koivisto UM; Miettinen HE; Miettinen TA
    Arterioscler Thromb Vasc Biol; 1997 Jan; 17(1):38-44. PubMed ID: 9012635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.